Patrickj Haley News Today

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month price objective among […]

Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They presently have a $28.00 target price on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 27.85% from the stock’s previous close. […]

Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $23.46, but opened at $21.64. Exelixis shares last traded at $21.17, with a volume of 911,024 shares trading hands. The biotechnology company reported $0.12 […]

Exelixis (NASDAQ:EXEL – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.16), Briefing.com reports. The company had revenue of $425.23 million during the quarter, compared to analysts’ expectations of $461.04 million. Exelixis had a return on equity […]

Exelixis (NASDAQ:EXEL – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.16), Briefing.com reports. The company had revenue of $425.23 million during the quarter, compared to analysts’ expectations of $461.04 million. Exelixis had a return on equity […]

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,620,000 shares, an increase of 26.2% from the March 31st total of 6,830,000 shares. Approximately 3.0% of the company’s shares are sold short. Based on an average […]

NewEdge Wealth LLC boosted its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 45.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 681,104 shares of the biotechnology company’s stock after buying an additional 212,553 shares during the period. NewEdge Wealth LLC’s holdings in Exelixis were worth $16,340,000 at the end of […]

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) traded down 3.9% on Thursday . The stock traded as low as $22.63 and last traded at $22.76. 275,501 shares changed hands during trading, a decline of 88% from the average session volume of 2,274,160 shares. The stock had previously closed at $23.68. Analysts Set New Price Targets […]

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12-month target price among brokerages […]

Exelixis (NASDAQ:EXEL – Get Free Report)‘s stock had its “market outperform” rating reiterated by JMP Securities in a note issued to investors on Wednesday, Benzinga reports. They currently have a $27.00 target price on the biotechnology company’s stock. JMP Securities’ target price indicates a potential upside of 14.55% from the stock’s current price. Several other […]